It can be easy to forget about geopolitics in the midst of a pandemic. But the UK’s relationship with the EU is set for a major change on December 31 and pharma companies must be prepared. Nik Kotecha’s advice is to look at all of your known knowns and unknown knowns, and start preparing for the unknown unknowns – simple! This week, you’ll also find a selection of news stories on: US drug importation from Canada, COVID-19 trials excluding the elderly, and The Medicine Maker’s 2020 Innovation awards – nominations are closing soon!

All the best, James Strachan, Deputy Editor

Don’t Exclude the Aged
10/14/2020 | Stephanie Sutton
Most clinical trials against COVID-19 exclude the very patients most at risk from the disease.
Top Tier Innovation
Nominate the top pharmaceutical technologies in our 2020 Innovation Awards.
Brexit Trading Unknowns
10/15/2020 | Nik Kotecha
Is your business prepared for Brexit? Here’s some advice from Nik Kotecha.
Importation Action
10/13/2020 | Stephanie Sutton
How will new guidance issued by the FDA affect drug importation?
Interested in AAV-based gene therapies?

Don’t miss our three-part educational webinar series with Cytiva that covers modern plasmid and AAV production for gene therapy applications. Find out more

Interested in out of specification and out of trend analysis?

Discover the key components of conducting OOT and OOS investigations in microbiology in our webinar with Cambrex on October 15. Find out more

Upcoming Webinar! AMLM: the perks of method performance verification in pharmaceutical quality framework

Join The Medicine Maker and Hovione on October 22, 2020 for an in depth discussion of AMLM Stage 3! Find out more

Discover how Terumo pre-fillable syringes are processed on Fill & Finish Lines

The parenteral injectable market has seen a noticeable uptake in polymer primary containers, including pre-fillable syringes with several benefits over glass systems for complex drug applications. REGISTER HERE!

Expand Your Operations Without Astronomical Costs!

Multimodal suites can help you shift your operations as technologies change, business expands, and patient needs evolve. Don’t miss our upcoming webinar with CRB’s SlateXpace on November 11, 2020. Find out more

White Papers
Use of NanoSight Sample Assistant to Increase Throughput and Reproducibility in the Physical Characterization of Exosomes

Nanosized plasma membrane vesicles secreted by cells into bodily fluids are known to have an important role in intracellular communication. Read more

Nanobubble Applications and Characterization

Acceptance of an interest in the special properties of nanobubbles and ultrafine bubbles is growing rapidly, and their formation and characteristics are the subject of an increasing amount of study. Read more

Product Profile
Fast track your path to high-confidence discovery & ID: Orbitrap Exploris 240 MS

From small- to large-molecule analyses, enjoy the power of leading performance, application versatility and operational simplicity with the Thermo ScientificTM Orbitrap ExplorisTM 240 mass spectrometer. Learn more

Special Promotions
Top Reasons to Choose Orbitrap MS over Q-TOF Instrumentation

Is peptide ID without quantitation sufficient for shotgun proteomics? The Thermo Scientific™ Orbitrap Exploris™ 240 MS meets your needs with leading quantitative performance, sensitivity and versatility. Learn more

A dedicated cell + gene therapy newsletter from The Medicine Maker team

Join 1,000s of peers from across the pharmaceutical, investment, and regulatory sectors for expert insight, analysis and words of wisdom on everything cell + gene therapy. Subscribe Now

Must-See Events Worldwide

We work with event organizers from all around the world to help bring the pharma industry together, from large congresses to intimate meetings that fit around a table. Discover some of the events that we partner with and and stay up-to-date with the latest developments.

Find out more